Immunohistochemistry demonstrated that the hepatic expression of CD61 as a PLT marker was markedly increased in liver tissue from NASH patients compared to liver tissue from simple steatosis patients (Figure 3A) and NASH mice (Figure 3B). The gene discussed is ITGB3; the disease is metabolic dysfunction-associated steatohepatitis.